Go to Client Portal

MD&M West 2024



Date(s) - February 6, 2024 - February 8, 2024 All Day


Anaheim Convention Center
800 W Katella Ave
Anaheim, CA 92802

NAMSA invites you to join us at MD&M West on February 6-8 in Anaheim, CA. MD&M West encourages innovation that results in solutions – both simple and complex – by building a community of experts, engineers, and thought leaders and bringing them together every year to engineer life-saving devices. Much more than a medical technology trade show, MD&M West exists to improve lives through continuing education, sharing knowledge, and bringing opportunities to all.


NAMSA will present a half-day training on February 6th from 1-5p, focused on the biological evaluation of medical devices: “The Biological Evaluation of Medical Devices—Choose your Adventure.” Led by a qualified instructor, attendees will choose their own adventure for medical devices through the evaluation process.

Presented will be information on two different devices and device pathways to regulatory acceptance focused on biological evaluation. During this time, attendees will provide input and choose an intended path, by device, based on which will yield regulatory acceptance. Key focal points of this adventure will be challenges faced by varying regulatory authorities, ISO 10993–1, 10993–18 and 10993–17, just to name a few.

This session is ideal for professionals with a basic understanding of the biological evaluation of medical devices and wish to further learn how an experienced leader would evaluate different devices for biological safety. For the less experienced attendees, we recommend a thorough review of any available webinars as well as reading of ISO 10993–1, 10993–18 and 10993–17 to better understand the process of the biological evaluation of medical devices.

Attendees of this session will:

  • Evaluate various details of what is known about materials and device histories to help outline biological evaluation plans
  • Demonstrate different paths to regulatory submission
  • Overcome challenges that may be presented by different regulatory agencies


Don Pohl, Principal Product Development Strategist

Don holds a Bachelor’s degree from Ohio State University and has over 25 years of experience in the preclinical evaluation of medical devices for biological safety. During his career, he has held a variety of positions ranging from laboratory supervision/management, GLP Study Director, Technical Specialist for Laboratory Information Management System, Technical Specialist and project manager for Biological safety and biological risk assessment consultation. He has specific expertise in the evaluation process outlined in ISO 10993-1 as well as the expectations of the USFDA and other countries in their interpretation of the biological safety evaluation of medical devices.